Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDistrib. Fin. Regulatory News (DFCH)

Share Price Information for Distrib. Fin. (DFCH)

Share Price is delayed by 15 minutes
Get Live Data
65.00    -0.50 (-0.76%)
Bid:
64.00
Ask:
66.00
Spread: 2.00 (3.125%)
Market Cap: £106.66m
DFCH Live PriceLast checked at - London Stock Exchange

Intraday Distrib. Fin. Share Chart

Board Update and Directorate Changes

13 May 2020 07:00

RNS Number : 6974M
Distribution Finance Cap. Hldgs PLC
13 May 2020
 

13 May 2020

Distribution Finance Capital Holdings plc ("DFC" or the "Company" or together with its subsidiaries the "DFC Group")

Board Update and Directorate Changes

The Company has relationship agreements in place with its two largest shareholders, Arrowgrass Master Fund Limited (AMFL) and Watrium AS. In line with market practice for such agreements, and as described in the Company's AIM Admission Document, both shareholders are entitled to appoint representative directors to the Board for as long as their shareholdings exceed agreed percentage thresholds.

As envisaged by these relationship agreements, both AMFL and Watrium AS recently informed the Company that they wished to appoint representative directors. The Board is therefore pleased to announce the appointment of Mr Stephen Greene (on behalf of AMFL) and Mr Haakon Stenrod (on behalf of Watrium AS) as Non-Executive Directors, with effect from today.

Mr Greene has investment banking, investing and capital markets experience, previously holding positions at Keel Harbour Capital Limited, Arrowgrass Capital Partners, RMG Wealth Management, ACPI Investments and Deutsche Bank. Recently he has transitioned into more technology focused roles, specifically within financial services and artificial intelligence, and currently serves as Managing Director of Orsus Ventures Limited and Coleura Labs Limited and formerly served as Managing Director of Satalia. Mr Greene has a Money, Banking and Finance degree from the University of Birmingham and is a Chartered Financial Analyst (CFA) charterholder.

Mr Stenrod is an Investment Director at Watrium AS. He was previously a partner with the leading Nordic investment banking group ABG Sundal Collier. He has broad transaction experience in M&A, equity capital markets, debt and restructuring advisory. He holds an M.Sc. in Industrial Economics and Technology Management from the Norwegian University of Science and Technology.

The Company also announces that Henry Kenner and James van den Bergh will be stepping down from the Board with immediate effect. Henry has been involved with DFC since its inception and has played an important part in the execution of the Company's strategy during that time. Alongside Henry, James joined the Board of DFC as a non-executive Director in the run-up to IPO in May 2019 to assist the Company as it transitioned from being a subsidiary of TruFin PLC to an independent company admitted to AIM. Henry is Chairman and James is CEO of TruFin plc and both remain shareholders of DFC.

Chairman John Baines commented:

"The entire firm is grateful to Henry and James for their support and advocacy of DF Capital. Without their enthusiasm and belief in the founders' vision much of what has been achieved by the company would not have been possible. Both have proven exceptional board colleagues and their wise counsel and experience has been valued by the entire board. Specifically, in relation to Henry, we appreciate him stepping in as Interim CEO last year and ensuring strategic momentum was not lost whilst we recruited a new permanent CEO and continued to progress the banking licence application. We wish both Henry and James well in their other commercial engagements beyond DFC.

The Board is delighted to welcome Stephen and Haakon as Non-Executive Directors and looks forward to working with them in supporting DFC's strategic ambitions."

Additional information required to be disclosed under Schedule Two of the AIM Rules:

Mr Greene, aged 43, currently holds or has held the following directorships and partnerships over the last five years:

Current:

Past:

Trufin plc.

Keel Harbour

Orsus Ventures Limited

Capital Limited

Coleura Labs Limited

Mr Greene currently has no shares in the Company in a personal capacity. AMFL owns 52,448,082 shares or 49.2% of the Company.

Mr Stenrod, aged 39, has no directorships and partnerships over the last five years to disclose under Schedule Two of the AIM Rules and currently has no shares in the Company in a personal capacity. His employer, Watrium AS, owns 14,833,922 shares or 13.9% of the Company.

Except as disclosed in this announcement, no other disclosures are required in respect of the appointment of Mr Greene or Mr Stenrod under paragraph (g) of Schedule Two of the AIM Rules for Companies.

For further information, please contact:

Enquiries:

 

Distribution Finance Capital Holdings plc

Carl D'Ammassa - Chief Executive Officer +44 (0) 20 3937 6390

http://www.dfcapital-investors.com

Macquarie Capital (Europe) Limited (NOMAD and broker)

Alex Reynolds +44 (0) 20 3037 2000

Jonny Allison

Blue Pool Communications (Financial PR)

Nick Lord +44 (0) 7501 271 083

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABCGDUGXBDGGD
Date   Source Headline
30th Oct 20241:00 pmRNSHolding(s) in Company
9th Oct 20247:00 amRNSQ3 trading update
4th Oct 20247:00 amRNSChief Financial Officer Retirement
19th Sep 20247:00 amRNSHalf-year Report
3rd Sep 202411:54 amRNSInvestor Presentation - Interim Results
29th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSENABLE guarantee extended
8th Jul 20242:56 pmRNSHolding(s) in Company
8th Jul 20247:45 amRNSHolding(s) in Company
4th Jul 20247:00 amRNSTrading Update
1st Jul 20247:00 amRNSNominated Adviser and Broker
5th Jun 20244:51 pmRNSResult of AGM
1st May 20244:47 pmRNSHolding(s) in Company
10th Apr 20244:07 pmRNSDirector/PDMR Shareholding
10th Apr 20249:00 amRNSNotice of AGM
9th Apr 20249:09 amRNSDirector/PDMR Shareholding
9th Apr 20247:01 amRNSAppointment of Nominated Adviser and Broker
9th Apr 20247:00 amRNSFinal Results
2nd Apr 202410:44 amRNSInvestor Presentation - Annual Results 2023
18th Mar 20247:00 amRNSTrading Update and Notice of Results
12th Mar 20243:48 pmRNSHolding(s) in Company
12th Mar 20241:00 pmRNSHolding(s) in Company
8th Mar 20243:19 pmRNSHolding(s) in Company
6th Mar 20243:00 pmRNSAIM Rule 17 schedule 2(g) update
10th Jan 20247:00 amRNSFull Year Trading Update
5th Dec 202312:22 pmRNSHolding(s) in Company
30th Nov 20235:18 pmRNSHolding(s) in Company
30th Nov 20234:14 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSTrading Statement
27th Nov 20238:50 amRNSHolding(s) in Company
3rd Oct 20237:00 amRNSQ3 Trading Update
29th Sep 20237:00 amRNSHalf-year Report
19th Sep 20237:00 amRNSHolding(s) in Company
15th Sep 20232:14 pmRNSHolding(s) in Company
15th Sep 202310:41 amRNSHolding(s) in Company
8th Sep 20237:00 amRNSTier 2 Capital Facility and Notice of Results
18th Aug 20237:00 amRNSIncrease in ENABLE Guarantee commitment
17th Aug 20233:57 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSTrading Update
3rd Jul 20233:57 pmRNSReduction of capital effective
24th May 20235:25 pmRNSAGM Statement
25th Apr 20238:47 amRNSNotice of AGM
21st Apr 202311:39 amRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSFinal Results
5th Apr 20237:00 amRNSTrading Update and Notice of Results
19th Jan 20237:01 amRNSAppointment of joint broker
19th Jan 20237:00 amRNSTrading Update
13th Jan 202312:39 pmRNSHolding(s) in Company
3rd Jan 20239:50 amRNSHolding(s) in Company
12th Oct 202211:37 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.